13D Filing: Starboard Value LP and Parexel International Corp (PRXL)
You can access the original SEC filing by clicking here.
Parexel International Corp (PRXL)
Market is closed
News
- 1 - 10
- Next >>
PAREXEL International Corporation (PRXL): Will Starboard Value Push For Sale?
Jeffrey Smith's Starboard Value has found its latest activist target in PAREXEL International Corporation (NASDAQ:PRXL), a company that provides consulting and other services to the biopharmaceutical ...
13D Filing: Starboard Value LP and Parexel International Corp (PRXL)
1. Sole power to vote or direct vote: 1,986,1772. Shared power to vote or direct vote: 03. Sole power to dispose or direct the disposition: 1,986,1774.
PAREXEL International Corporation (PRXL): Are Hedge Funds Right About This Stock?
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
Billionaire Ken Fisher Loves These Small-Cap Stocks
Ken Fisher’s Fisher Asset Management is one of the largest funds out of the universe of over 700 hedge funds that we track at Insider Monkey.
United Rentals Inc. (URI), Techne Corporation (TECH), SBA Communications Corporation (SBAC): Amongst Rail-Splitter Capital Management’s Top Picks from Q2
John Croghan and Richard Fradin’s Rail-Splitter Capital Management has recently disclosed its long equity positions for the second quarter of 2014 in a filing with the SEC.
SVB Financial Group (SIVB), Waddell & Reed Financial Inc. (WDR), Domino’s Pizza Inc. (DPZ): Ken Fisher’s Top Small-Cap Picks
Although chances of outperforming the wider market by emulating hedge fund picks is quite unlikely, odds increase when you focus on small-cap companies ($1 billion-$5billion market cap, approximately).
What Hedge Funds Think About Covance Inc. (CVD)
If you were to ask many of your peers, hedge funds are viewed as overrated, outdated financial tools of a period lost to current times.
Covance Inc. (CVD), PAREXEL International Corporation (PRXL): Outsourcing Your Laboratory
The increasing cost of drug development coupled with long delays in regulatory approvals has made R&D a daunting task for small drug developers.
Hedge Funds Are Buying Ironwood Pharmaceuticals, Inc. (IRWD)
In the 21st century investor’s toolkit, there are plenty of indicators market participants can use to analyze their holdings.
- 1 - 10
- Next >>
Billionaire Hedge Funds
